Press Releases

“When it comes to dedication, ICTS is second to none. Our study was in crisis mode. Everything we tried had failed. ICTS developed a novel approach to physician referral that prevented yet another round of adding investigators.”
Project Director, Top 50 Pharmaceutical Company

Go back to Press Releases

ICTS Completes Orphan Drug Study

  • October 08
  • by Gregg Sweet

Integrated Clinical Trial Services (ICTS) has completed the recruitment for an orphan drug study in 16 countries. Support for these studies began in March of 2018 and was completed in July 2018, approximately 6 months ahead of schedule.